Challenges

The field of preclinical oncology research is being hit by a new wave of innovation, specifically innovation in disease model sourcing for drug...

Biotechnology companies aim to develop products and technologies that can solve the many health-related problems that plague our world today. The...

By Maria Menikou, Category Director, Human Biological Samples at Scientist.com and Gina Dunne Smith, Executive Director at International Institute...

Over the past weeks, Scientist.com has been working hard to listen, learn and implement short-term and long-term changes regarding diversity within...

The first occurrence of human infections of the novel Coronavirus (COVID-19) was recognized in Wuhan, China. Due to its fast spreading and...

Though much of the world is hearing about them for the first time, coronaviruses are a large family of related viruses responsible for respiratory...

Chilling stories and movie plots depicting a hidden, global black market for human biospecimen such as organs, tissue and other elements of the...

Drug discovery, ever a challenge, can be likened to a tall structure. The upper stories rely on the stability of the floors below it, and a solid...

It’s a sad story that everyone is familiar with: A patient takes one or more well-known cancer drugs, and they work – for a while. However, after...

The vast majority of compounds that enter clinical trials fail to make it through. The result: few drugs, plenty of bills. The consensus in drug...